Literature DB >> 29551142

How Does Vaccinia Virus Interfere With Interferon?

Geoffrey L Smith1, Callum Talbot-Cooper2, Yongxu Lu2.   

Abstract

Interferons (IFNs) are secreted glycoproteins that are produced by cells in response to virus infection and other stimuli and induce an antiviral state in cells bearing IFN receptors. In this way, IFNs restrict virus replication and spread before an adaptive immune response is developed. Viruses are very sensitive to the effects of IFNs and consequently have evolved many strategies to interfere with interferon. This is particularly well illustrated by poxviruses, which have large dsDNA genomes and encode hundreds of proteins. Vaccinia virus is the prototypic poxvirus and expresses many proteins that interfere with IFN and are considered in this review. These proteins act either inside or outside the cell and within the cytoplasm or nucleus. They function by restricting the production of IFN by blocking the signaling pathways leading to transcription of IFN genes, stopping IFNs binding to their receptors, blocking IFN-induced signal transduction leading to expression of interferon-stimulated genes (ISGs), or inhibiting the antiviral activity of ISG products.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AP-1; GAS; IRF3; ISRE; Innate immunity; Interferon; Interferon alpha/beta; Interferon gamma; Interferon lambdas; Interferon receptors; Interferon-inducible genes; JAK–Stat; NF-κB; Signaling pathways; Smallpox; Vaccine; Vaccinia virus

Mesh:

Substances:

Year:  2018        PMID: 29551142     DOI: 10.1016/bs.aivir.2018.01.003

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN: 0065-3527            Impact factor:   9.937


  18 in total

1.  Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.

Authors:  Xufang Deng; Alexandra C Buckley; Angela Pillatzki; Kelly M Lager; Kay S Faaberg; Susan C Baker
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  mTOR Dysregulation by Vaccinia Virus F17 Controls Multiple Processes with Varying Roles in Infection.

Authors:  Nathan Meade; Melvin King; Joshua Munger; Derek Walsh
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

3.  Poxviruses Evade Cytosolic Sensing through Disruption of an mTORC1-mTORC2 Regulatory Circuit.

Authors:  Nathan Meade; Colleen Furey; Hua Li; Rita Verma; Qingqing Chai; Madeline G Rollins; Stephen DiGiuseppe; Mojgan H Naghavi; Derek Walsh
Journal:  Cell       Date:  2018-08-02       Impact factor: 41.582

4.  Ribosome quality control activity potentiates vaccinia virus protein synthesis during infection.

Authors:  Elayanambi Sundaramoorthy; Andrew P Ryan; Amit Fulzele; Marilyn Leonard; Matthew D Daugherty; Eric J Bennett
Journal:  J Cell Sci       Date:  2021-04-28       Impact factor: 5.285

5.  Dysregulation of Cellular VRK1, BAF, and Innate Immune Signaling by the Vaccinia Virus B12 Pseudokinase.

Authors:  Alexandria C Linville; Amber B Rico; Helena Teague; Lucy E Binsted; Geoffrey L Smith; Jonas D Albarnaz; Matthew S Wiebe
Journal:  J Virol       Date:  2022-05-11       Impact factor: 6.549

6.  Collateral Lethal Effects of Complementary Oncolytic Viruses.

Authors:  Justin W Maroun; Velia Penza; Taylor M Weiskittel; Autumn J Schulze; Stephen J Russell
Journal:  Mol Ther Oncolytics       Date:  2020-06-24       Impact factor: 7.200

7.  Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6.

Authors:  Yongxu Lu; Jennifer H Stuart; Callum Talbot-Cooper; Shuchi Agrawal-Singh; Brian Huntly; Andrei I Smid; Joseph S Snowden; Liane Dupont; Geoffrey L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-24       Impact factor: 11.205

Review 8.  Poxviral Strategies to Overcome Host Cell Apoptosis.

Authors:  Chathura D Suraweera; Mark G Hinds; Marc Kvansakul
Journal:  Pathogens       Date:  2020-12-23

9.  Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo.

Authors:  Xue Wang; Ningning Zhou; Tingting Liu; Xiaoyuan Jia; Ting Ye; Kan Chen; Gongchu Li
Journal:  Mar Drugs       Date:  2021-05-21       Impact factor: 5.118

Review 10.  DNA-Sensing Antiviral Innate Immunity in Poxvirus Infection.

Authors:  Yue Lu; Leiliang Zhang
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.